Datadog's Q4-24 earnings showed strong multi-product adoption, with 50% of clients using four or more products. The company's record $1B in bookings in Q4-24 highlights momentum, but Q1-25 guidance was below expectations. Datadog's AI-native clients now represent ~6% of ARR, driving a five percentage-point contribution to YoY topline growth.

Hedge fund Qube Research & Technologies unveiled a roughly $105 million short position against shares in Trump Media & Technology Group on Monday, according to a filing with Germany's federal Gazette Bundesanzeiger.

M&T Bank Corporation (NYSE:MTB ) Q1 2025 Earnings Conference Call April 14, 2025 8:00 AM ET Company Participants Steve Wendelboe - Senior Vice President, Investor Relations Daryl Bible - Senior Executive Vice President & CFO Conference Call Participants Ken Houston - Autonomous Research Ebrahim Poonawala - Bank of America Gerard Cassidy - RBC Matt O'Connor - Deutsche Bank Manan Gosalia - Morgan Stanley John Pancari - Evercore Christopher Spahr - Wells Fargo Peter Winter - D.A. Davidson Erika Najarian - UBS Operator Welcome to the M&T Bank First Quarter 2025 Earnings Conference Call.

Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.

Nvidia has made its manufacturing debut in the US and plans to expand its presence. The chipmaker announced it plans to "build and test NVIDIA Blackwell chips in Arizona and AI supercomputers in Texas.

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

Sony (SONY) has raised PlayStation 5 prices in international markets including the Europe, Australia, and New Zealand, citing a "challenging economic environment, including high inflation and fluctuating exchange rates."

International Paper inks deal to sell five corrugated box plants in Europe as agreed with the European Commission following its acquisition of DS Smith.

LOS ANGELES--(BUSINESS WIRE)--NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.

Verve Therapeutics Inc VERV on Monday released initial data from the Heart-2 Phase 1b trial of VERVE-102 in patients with heterozygous familial hypercholesterolemia (HeFH) and/or premature coronary artery disease (CAD), which requires reducing low-density lipoprotein cholesterol (LDL-C) levels in the blood.

CARY holds a diversified portfolio of bonds, focusing on short-term investment-grade securities, mainly MBS. The fund's active management strategy, including overweighting MBS, has led to higher returns and outperformance compared to its benchmark and most bonds. CARY sports an above-average 5.0% yield, below-average risk and volatility, and has outperformed most peers since inception.

Advanced Micro Devices, Inc.'s stock has underperformed despite strong growth in revenue, net income, and promising market positioning in AI hardware under Dr. Lisa Su's leadership. Nvidia dominates AI training hardware because of CUDA, but AMD's cost-efficient, open-source ROCm platform is gaining traction for AI inference, especially with firms like Meta. AMD's chiplet approach offers superior cost efficiency compared to Nvidia, making it a compelling choice for AI hardware investments.

A potentially weeks-long trial begins for Meta Platforms (META) to keep its Instagram and WhatsApp platforms. The FTC seeks to divest the platforms from Meta after accusing the company of using them to maintain its dominant position.

As Pres. Trump pulls back on his tariff policy, Apple (AAPL) is among the early stocks to pop higher. Meanwhile, Meta Platforms (META) faces antitrust headwinds as the FTC begins its trial with WhatsApp and Instagram's ownership on the line.

Top Meta executives including Mark Zuckerberg and ex-operating chief Sheryl Sandberg will be in the hot seat as the Federal Trade Commission's landmark antitrust trial seeking a breakup of Meta kicked off on Monday.

The current economic landscape feels like a tightrope walk for investors.

Amid market turmoil, investors often fly to the safety of dividend growth stocks to wait out the storm.

Thermo Fisher Scientific shows strong fundamentals, consistent earnings growth, and solid financial health, making it a viable long-term investment. TMO's recent product expansion, including the breakthrough Krios 5 Cryo-TEM technology, is expected to drive future growth and support earnings. Valuation metrics indicate TMO is currently undervalued.

While gold continues to capture investor attention in a volatile macro environment, its industrial cousins (silver, platinum and palladium) have failed to keep pace. UBS has now scaled back its price forecasts for these so-called white precious metals, citing slower economic growth and weak investor sentiment.

Facebook parent faces threats of illegal social media monopoly after spending billions to acquire two platforms